Michael J. Zelefsky

In this engaging conversation, Dr. Michael J. Zelefsky, a leading figure in radiation oncology from NYU Grossman School of Medicine, explores how MRI-LINAC technology is revolutionizing prostate cancer treatment. He discusses the shift from lengthy radiation sessions to just five ultra-precise treatments. Listeners will learn about the distinctions between SBRT and IMRT, the advantages of photons over protons, and the future potential of AI and genomics in personalized cancer care. Dr. Zelefsky paints an optimistic picture of advanced imaging technologies enhancing patient outcomes.